The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function
- PMID: 11728286
The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function
Abstract
Hypertension is a syndrome in which dysfunction of the blood vessels and of neuroendocrine systems play a major role. Arteriosclerosis and atherosclerosis are distinct processes in arterial disease. Arteriosclerosis begins with thickening and hardening of the arterial wall, with loss of elasticity. Atherosclerosis is an inflammatory process that begins with endothelial dysfunction, and leads to vascular occlusion. The endothelial dysfunction that causes atherosclerosis and coronary artery disease results from an imbalance between nitric oxide and angiotensin-II. This balance becomes tipped toward angiotensin-II in the presence of hypertension. When arteries stiffen as a result of hypertension and aging, they are not able to store blood volume properly, systolic blood pressure rises, and pulse pressure widens. Because the tissue renin-angiotensin system is responsible for promoting the adverse structural arterial changes, inhibition of angiotensin-converting enzyme (ACE) is effective in restoring the health of both large and small arteries by blocking angiotensin and by increasing bradykinin.
Similar articles
-
Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.J Hum Hypertens. 2004 Sep;18(9):599-606. doi: 10.1038/sj.jhh.1001714. J Hum Hypertens. 2004. PMID: 15190263 Review.
-
Vascular protection: current possibilities and future perspectives.Int J Clin Pract Suppl. 2001 Jan;(117):3-6. Int J Clin Pract Suppl. 2001. PMID: 11715356 Review.
-
Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.Postgrad Med. 2000 Oct;108(5 Suppl):4-11. doi: 10.3810/pgm.10.2000.suppl8.45. Postgrad Med. 2000. PMID: 19667535
-
[Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].Schweiz Med Wochenschr. 1997 Apr 12;127(15):636-49. Schweiz Med Wochenschr. 1997. PMID: 9198890 Review. German.
-
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.
Cited by
-
The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH).J Clin Hypertens (Greenwich). 2003 Jul-Aug;5(4 Suppl 3):29-35. doi: 10.1111/j.1524-6175.2003.02676.x. J Clin Hypertens (Greenwich). 2003. PMID: 12941995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous